Sedat Evran serves as Executive at BIO-RAD LABORATORIES, INC., where they oversee executive responsibilities. Since joining the company, Sedat Evran has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Oct 20, 2025 involved exercising options for 1,044 shares valued at $0.
Sedat Evran currently holds 2,567.85 shares of BIO-RAD LABORATORIES, INC. (BIO BIO.B), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sedat Evran has been a net neutral trader of BIO BIO.B stock. They have purchased $0 and sold $0 worth of shares.
Sedat Evran's most recent insider trade was on Oct 20, 2025, when they sold 1,044 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| 335 |
| $321.90 |
| Discretionary |
| Sep 6, 2025 | BIO BIO.B | $0 | Option Exercise | 864 | $N/A | Discretionary |
| Sep 6, 2025 | BIO BIO.B | $81.8K | Payment | 277 | $295.43 | Discretionary |